18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

Prostate-specific membrane antigen expression in normal and malignant human tissues.

Donald Silver, I Pellicer, W R Fair et al. · PubMed · 1997 · 1.5K citations

Medicine, Oncology, Pathology +16

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2017 · 1.3K citations

Medicine, Oncology, Urology +17

Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

Matthias Eiber, Tobias Maurer, Michael Souvatzoglou et al. · Journal of Nuclear Medicine · 2015 · 995 citations

Medicine, Nuclear Medicine, Radiology +14

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 974 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

⁶⁸Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst et al. · Bioconjugate Chemistry · 2012 · 841 citations

Medicine, Oncology, Pharmacology +17